Welcome to LookChem.com Sign In|Join Free
  • or
[4-(4-aminobenzamido)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1432017-45-2

Post Buying Request

1432017-45-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1432017-45-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1432017-45-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,2,0,1 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1432017-45:
(9*1)+(8*4)+(7*3)+(6*2)+(5*0)+(4*1)+(3*7)+(2*4)+(1*5)=112
112 % 10 = 2
So 1432017-45-2 is a valid CAS Registry Number.

1432017-45-2Downstream Products

1432017-45-2Relevant academic research and scientific papers

Synthesis and identification of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential Aurora A inhibitors

Sang, Chun-Yan,Qin, Wen-Wen,Zhang, Xiu-Juan,Xu, Yu,Ma, You-Zhen,Wang, Xing-Rong,Hui, Ling,Chen, Shi-Wu

, p. 65 - 78 (2018/11/30)

The Aurora kinases are a family of serine/threonine kinases that interact with components of the mitotic apparatus and serve as potential therapeutic targets in oncology. Herein, we reported a series of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl with selective inhibition of Aurora A in either enzymatic assays or cellular phenotypic assays, and displaying more potent anti-proliferation compared with that of VX-680. The most potent compound 10a forms better interaction with Aurora A than Aurora B in molecular docking. Mechanistic studies revealed that 10a disrupt the spindle formation, block the cell cycle progression in the G2/M phase and induce apoptosis in HeLa cell. These results suggested that the produced series of compounds are potential anticancer agents for further development as selective Aurora A inhibitors.

Aurora kinase A inhibitor and preparation and application thereof

-

Paragraph 0027; 0028; 0029, (2017/07/12)

The invention discloses a novel stable nitroxide radical-marked aurora kinase A inhibitor and a preparation method and application thereof. The aurora kinase A inhibitor is N-(5-fluoro-4-o-chloroaniline-pyrimidin-2)-aminobenzoic acid 4-amino-2, 2, 6, 6-tetramethylpiperidyl oxynitride amide, or N-{5-fluoro-4-amino-(benzoyl o-chloroaniline)-pyrimidin-2}-aminobenzoic acid 4-amino-2, 2, 6, 6-tetramethylpiperidyl oxynitride amide. According to the preparation method, a target compound is prepared by performing a substitution reaction on 2, 4-dichloro-5-substituted-pyrimidine and aniline or p-aminobenzanilide and then 4-amino-2, 2, 6, 6-tetramethylpiperidyl nitrogen oxide. The aurora kinase A inhibitor is applied to preparation of anticancer medicines.

A facile route to steady redox-modulated nitroxide spin-labeled surfaces based on diazonium chemistry

Cougnon, Charles,Boisard, Severine,Cador, Olivier,Dias, Marylene,Levillain, Eric,Breton, Tony

, p. 4555 - 4557 (2013/06/05)

A TEMPO derivative was covalently grafted onto carbon and gold surfaces via the diazonium chemistry. The acid-dependent redox properties of the nitroxyl group were exploited to elaborate electro-switchable magnetic surfaces. ESR characterization demonstra

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1432017-45-2